Scarless healing of oral mucosa is characterized by faster resolution of inflammation and control of myofibroblast action compared to skin wounds in the red Duroc pig model.
Level 5 - mechanism / opinion, no new human data
Preclinical animal study without human data.
PubMed 19854029 · doi:10.1016/j.jdermsci.2009.09.005
What was done
Researchers created large experimental wounds (17 times larger than those previously tested) in both the oral mucosa and dorsal skin of red Duroc pigs. They compared clinical and histological scar formation, wound contraction, and the localization and abundance of inflammatory cells (macrophages and mast cells), myofibroblasts, transforming growth factor-beta (TGF-beta), and phosphorylated Smad3 (pSmad3) between the two tissue sites.
What was found
No exact numerical values were reported in the abstract. Oral mucosal wounds demonstrated significantly less clinical and histological scar formation and significantly less contraction over time than skin wounds. During the maturation phase, oral wounds showed significantly reduced numbers of macrophages, mast cells, and TGF-beta- and pSmad3-immunopositive cells compared to skin wounds. Although myofibroblast numbers were significantly higher in oral wounds, overall wound contraction remained significantly lower.
Why it matters
The study suggests that scarless oral healing involves faster resolution of inflammation and differential regulation of myofibroblast activity by the local tissue environment, highlighting potential pathways to limit scarring in cutaneous wounds.
Limits
Findings are from an animal model (red Duroc pigs) and may not fully replicate human tissue biology. The abstract does not disclose the sample size, wound dimensions, follow-up timeline, or quantitative data and effect sizes for the cellular and molecular markers.
Cited by
- supports Wounds to the oral mucosa heal with significantly less or zero scar formation compared to cutaneous skin wounds.